Tackling trial diversity in a biased clinical development landscape
Experts at Clinical Trials in Oncology West Coast discussed the need for purposeful action and adaptive strategies.
Experts at Clinical Trials in Oncology West Coast discussed the need for purposeful action and adaptive strategies.
PhaseV will analyse NeuroSense’s Phase II ALS trial data, and results from these will inform Phase III trial design, enrolment, and cost-effectiveness.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
MMI pioneers Symani Surgical System in first US cases
“Defensibility” key for AI-centric small biotechs seeking investment
Klineo wins €2m to advance AI patient recruitment platform
Hyperfine starts enrolment in portable imaging workflow study